{
  "main_header": {
    "sid": 799751,
    "name": "Pharmaids Pharma",
    "stock_name": "Pharmaids Pharma",
    "full_name": "Pharmaids Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/pharmaids-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "66.70",
    "chg": -0.29,
    "chgp": "-0.43%",
    "dir": -1,
    "prev_price": "66.99",
    "mcapval": "236.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524572,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE117D01018",
    "curr_date": "Apr 11, 12:50 PM",
    "curr_time": "01:29 AM",
    "bse_nse_vol": "15.45 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/pharmaids-pharma-799751-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Pharmaids Pharmaceuticals Ltd Surges Amid Strong Buying Activity and Sector Gains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pharmaids-pharmaceuticals-ltd-surges-5-01-today-outperforming-sensex-amid-strong-buying-activity-1693622",
        "imagepath": "",
        "date": "2025-04-03 09:35:24",
        "description": "Pharmaids Pharmaceuticals Ltd is witnessing significant buying activity, with the stock rising by 5.01% today, contrasting sharply with the Sensex, which has declined by 0.58%. This marks a notable performance, especially considering the stock's 1-week gain of 3.64% against the Sensex's drop of 1.85%. Over the past month, Pharmaids has maintained a steady performance, matching the Sensex's 4.22% increase.\n\nThe stock opened with a gap up of 4.26% and reached an intraday high of Rs 71.51, reflecting strong buyer sentiment. The stock has consistently outperformed its sector, which has gained 4.06% today. Additionally, Pharmaids is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a robust upward trend.\n\nDespite a 7.11% decline over the past three months, the stock has shown impressive long-term performance, with a staggering 452.20% increase over three years and an extra..."
      },
      {
        "title": "Pharmaids Pharmaceuticals Surges 4.99% Amidst Broader Market Decline, Showcases Strong Resilience",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pharmaids-pharmaceuticals-ltd-surges-4-99-today-marks-16-53-weekly-gain-amid-market-decline-1103802",
        "imagepath": "",
        "date": "2025-02-24 10:27:06",
        "description": "Pharmaids Pharmaceuticals Ltd is currently witnessing significant buying activity, with the stock gaining 4.99% today, contrasting sharply with the Sensex, which has declined by 0.97%. Over the past week, Pharmaids has shown a robust performance, increasing by 16.53%, while the Sensex has dropped by 1.86%. This trend highlights the stock's resilience, particularly in a challenging market environment.\n\nThe stock has been on a positive trajectory for the last three days, accumulating a total return of 13.86%. It opened today with a gap up of 4.99% and reached an intraday high of Rs 70.48. The trading range has been narrow, with only Rs 0.18 fluctuation, indicating strong buying support at current levels.\n\nPharmaids Pharmaceuticals has consistently outperformed the sector, with its performance today exceeding sector benchmarks by 4.69%. Additionally, the stock is trading above its 5-day, 20-day, 50-day, 100-da..."
      },
      {
        "title": "Pharmaids Pharmaceuticals Sees Strong Buying Activity Amid Broader Market Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pharmaids-pharmaceuticals-ltd-surges-4-99-today-accumulates-8-45-gains-over-two-days-1075861",
        "imagepath": "",
        "date": "2025-02-21 09:57:29",
        "description": "Pharmaids Pharmaceuticals Ltd is currently witnessing significant buying activity, with the stock gaining 4.99% today, contrasting sharply with the Sensex, which has declined by 0.38%. Over the past week, Pharmaids has recorded a total increase of 5.05%, while the Sensex has fallen by 0.65%. Notably, the stock has shown consecutive gains over the last two days, accumulating a total return of 8.45%.\n\nThe stock opened with a gap up at Rs 67.13 and reached an intraday high of the same price, indicating strong buyer interest at this level. Despite a challenging month where the stock is down 9.89%, its year-to-date performance shows a decline of 4.75%, slightly worse than the Sensex's 3.45% drop. However, over the longer term, Pharmaids Pharmaceuticals has demonstrated remarkable growth, with a three-year increase of 406.64% and a staggering 1258.91% rise over five years.\n\nThe current buying pressure may be attr..."
      },
      {
        "title": "Pharmaids Pharmaceuticals Sees Strong Buying Activity Amid Broader Market Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pharmaids-pharmaceuticals-ltd-gains-3-30-today-rebounding-from-weekly-low-amid-market-decline-1065158",
        "imagepath": "",
        "date": "2025-02-20 10:17:44",
        "description": "Pharmaids Pharmaceuticals Ltd is witnessing significant buying activity today, with the stock rising by 3.30%, contrasting sharply with the Sensex's decline of 0.36%. This performance marks a notable rebound after a challenging week, where the stock had previously decreased by 4.57%. Over the past month, Pharmaids has faced a decline of 14.23%, yet its year-to-date performance shows a decrease of 9.28%, compared to the Sensex's 3.17% drop.\n\nThe stock opened with a gap down of 4.07% today but managed to reach an intraday high of Rs 63.94, reflecting a recovery from earlier lows of Rs 59.38. Despite recent struggles, Pharmaids Pharmaceuticals has demonstrated impressive long-term growth, with a staggering 380.75% increase over the past three years and an extraordinary 1194.33% rise over five years.\n\nThe current buying pressure may be attributed to various factors, including market sentiment and potential deve..."
      },
      {
        "title": "Pharmaids Pharmaceuticals Reports Strong Sales Growth Amid Operational Efficiency Challenges in February 2025",
        "link": "https://www.marketsmojo.com/news/result-analysis/pharmaids-pharmaceuticals-reports-49650-sales-growth-and-improved-debtors-turnover-in-december-2024-996061",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/PharmaidsPharma_quaterlyResult_423226.png",
        "date": "2025-02-12 22:51:13",
        "description": "Pharmaids Pharmaceuticals announced its financial results for the quarter ending December 2024, highlighting significant growth in net sales at Rs 9.95 crore, driven by strong product demand. The company achieved its highest Debtors Turnover Ratio in recent periods, although it faced challenges with a low operating profit margin."
      }
    ],
    "total": 16,
    "sid": "799751",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/pharmaids-pharmaceuticals-799751"
  },
  "announcements": [
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "09-Apr-2025",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Pharmaids Pharmaceuticals Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L52520KA1989PLC173979</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Prasanna Subramanya Bhat <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: prasanna@pharmaids.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Balagangadhara B C <br/> Designation: Cheif Financial Officer <br/> EmailId: bg@pharmaids.com</div> </div> <div> <br/> Date: 09/04/2025<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "04-Apr-2025",
      "details": "Certificate under Regulation 74(5) of SEBI (DP) Regulation 2018 for the quarter ended March 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of Loan Agreement",
      "datetime": "28-Mar-2025",
      "details": "Disclosure under Regulation 30 of SEBI (LODR) Regulation 2015 - Intimation of Loan agreement",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Pharmaids Pharmaceuticals Ltd Surges Amid Strong Buying Activity and Sector Gains

2025-04-03 09:35:24

Pharmaids Pharmaceuticals Ltd is witnessing significant buying activity, with the stock rising by 5.01% today, contrasting sharply with the Sensex, which has declined by 0.58%. This marks a notable performance, especially considering the stock's 1-week gain of 3.64% against the Sensex's drop of 1.85%. Over the past month, Pharmaids has maintained a steady performance, matching the Sensex's 4.22% increase. The stock opened with a gap up of 4.26% and reached an intraday high of Rs 71.51, reflecting strong buyer sentiment. The stock has consistently outperformed its sector, which has gained 4.06% today. Additionally, Pharmaids is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a robust upward trend. Despite a 7.11% decline over the past three months, the stock has shown impressive long-term performance, with a staggering 452.20% increase over three years and an extra...

Read More

Pharmaids Pharmaceuticals Surges 4.99% Amidst Broader Market Decline, Showcases Strong Resilience

2025-02-24 10:27:06

Pharmaids Pharmaceuticals Ltd is currently witnessing significant buying activity, with the stock gaining 4.99% today, contrasting sharply with the Sensex, which has declined by 0.97%. Over the past week, Pharmaids has shown a robust performance, increasing by 16.53%, while the Sensex has dropped by 1.86%. This trend highlights the stock's resilience, particularly in a challenging market environment. The stock has been on a positive trajectory for the last three days, accumulating a total return of 13.86%. It opened today with a gap up of 4.99% and reached an intraday high of Rs 70.48. The trading range has been narrow, with only Rs 0.18 fluctuation, indicating strong buying support at current levels. Pharmaids Pharmaceuticals has consistently outperformed the sector, with its performance today exceeding sector benchmarks by 4.69%. Additionally, the stock is trading above its 5-day, 20-day, 50-day, 100-da...

Read More

Pharmaids Pharmaceuticals Sees Strong Buying Activity Amid Broader Market Decline

2025-02-21 09:57:29

Pharmaids Pharmaceuticals Ltd is currently witnessing significant buying activity, with the stock gaining 4.99% today, contrasting sharply with the Sensex, which has declined by 0.38%. Over the past week, Pharmaids has recorded a total increase of 5.05%, while the Sensex has fallen by 0.65%. Notably, the stock has shown consecutive gains over the last two days, accumulating a total return of 8.45%. The stock opened with a gap up at Rs 67.13 and reached an intraday high of the same price, indicating strong buyer interest at this level. Despite a challenging month where the stock is down 9.89%, its year-to-date performance shows a decline of 4.75%, slightly worse than the Sensex's 3.45% drop. However, over the longer term, Pharmaids Pharmaceuticals has demonstrated remarkable growth, with a three-year increase of 406.64% and a staggering 1258.91% rise over five years. The current buying pressure may be attr...

Read More

Pharmaids Pharmaceuticals Sees Strong Buying Activity Amid Broader Market Decline

2025-02-20 10:17:44

Pharmaids Pharmaceuticals Ltd is witnessing significant buying activity today, with the stock rising by 3.30%, contrasting sharply with the Sensex's decline of 0.36%. This performance marks a notable rebound after a challenging week, where the stock had previously decreased by 4.57%. Over the past month, Pharmaids has faced a decline of 14.23%, yet its year-to-date performance shows a decrease of 9.28%, compared to the Sensex's 3.17% drop. The stock opened with a gap down of 4.07% today but managed to reach an intraday high of Rs 63.94, reflecting a recovery from earlier lows of Rs 59.38. Despite recent struggles, Pharmaids Pharmaceuticals has demonstrated impressive long-term growth, with a staggering 380.75% increase over the past three years and an extraordinary 1194.33% rise over five years. The current buying pressure may be attributed to various factors, including market sentiment and potential deve...

Read More

Pharmaids Pharmaceuticals Reports Strong Sales Growth Amid Operational Efficiency Challenges in February 2025

2025-02-12 22:51:13

Pharmaids Pharmaceuticals announced its financial results for the quarter ending December 2024, highlighting significant growth in net sales at Rs 9.95 crore, driven by strong product demand. The company achieved its highest Debtors Turnover Ratio in recent periods, although it faced challenges with a low operating profit margin.

Read More

View All News